Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer

Epigenetics

Volumn 10, Issue 10, 2015, Pages 970-980

  Lando, Malin ^a   Fjeldbo, Christina S ^a   Wilting, Saskia M ^b   Snoek, Barbara C ^b   Aarnes, Eva Katrine ^a   Forsberg, Malin F ^a   Kristensen, Gunnar B ^a,c,d   Steenbergen, Renske D M ^b   Lyng, Heidi ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

3p; Cervical cancer; Chromosomal loss; Gene expression; Integrative genomic profiling; Promoter methylation; Tumor suppressor genes

Indexed keywords

CISPLATIN; TUMOR PROTEIN;

ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CARCINOGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE DOSAGE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; KERATINOCYTE; MAJOR CLINICAL STUDY; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; SURVIVAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; WART VIRUS; ADULT; AGED; BIOSYNTHESIS; CHROMOSOME 3; CHROMOSOME DELETION; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX TUMOR;

ADULT; AGED; CARCINOGENESIS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; CPG ISLANDS; DISEASE-FREE SURVIVAL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 84953399506     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2015.1085140     Document Type: Article

References (43)

1. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4:143-53.; PMID:14732866; http://dx.doi.org/10.1038/nrc1279
2. Herman JG. Hypermethylation of tumor suppressor genes in cancer. Semin.Cancer Biol 1999; 9:359-67; http://dx.doi.org/10.1006/scbi.1999.0138
3. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML. et al. DNA copy number losses in human neoplasms. Am.J.Pathol 1999; 155:683-94.; PMID:10487825; http://dx.doi.org/10.1016/S0002-9440(10)65166-8
4. van De Strooper LM, Zummeren M, Steenbergen RD, Bleeker MC, Hesselink AT, Wisman GB, Snijders PJ, Heideman DA, Meijer CJ. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. J Clin Pathol 2014; 67:1067-71.; PMID:25281766; http://dx.doi.org/10.1136/jclinpath-2014-202616
5. Lando M, Holden M, Bergersen LC, Svendsrud DH, Stokke T, Sundfor K, Glad IK, Kristensen GB, Lyng H. Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer. PLoS Genet 2009; 5: e1000719.; PMID:19911042; http://dx.doi.org/10.1371/journal.pgen.1000719
6. Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 96:294-305.; PMID:14970278; http://dx.doi.org/10.1093/jnci/djh031
7. Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, Meijer CJ, Snijders PJ, Steenbergen RD. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 2009; 219:327-36.; PMID:19662663; http://dx.doi.org/10.1002/path.2598
8. Mine KL, Shulzhenko N, Yambartsev A, Rochman M, Sanson GF, Lando M, Varma S, Skinner J, Volfovsky N, Deng T. et al. Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun 2013; 4:1806.; PMID:23651994; http://dx.doi.org/10.1038/ncomms2693
9. Tang MH, Varadan V, Kamalakaran S, Zhang MQ, Dimitrova N, Hicks J. Major chromosomal breakpoint intervals in breast cancer co-localize with differentially methylated regions. Front Oncol 2012; 2: 197.; PMID:23293768; http://dx.doi.org/10.3389/fonc.2012.00197
10. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28.; PMID:12042769; http://dx.doi.org/10.1038/nrg962
11. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107-16.; PMID:16491070; http://dx.doi.org/10.1038/nrc1799
12. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG. et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26:16-7.; PMID:10973239; http://dx.doi.org/10.1038/79120
13. Myohanen SK, Baylin SB, Herman JG. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 1998; 58:591-3.; PMID:9485004
14. Pandis N, Bardi G, Mitelman F, Heim S. Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosomes Cancer 1997; 18:241-5.; PMID:9087563; http://dx.doi.org/10.1002/(SICI)1098-2264(199704)18:4%3c241::AID-GCC1%3e3.0.CO;2-0
15. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002; 21:6915-35.; PMID:12362274; http://dx.doi.org/10.1038/sj.onc.1205835
16. Lando M, Wilting SM, Snipstad K, Clancy T, Bierkens M, Aarnes EK, Holden M, Stokke T, Sundfor K, Holm R. et al. Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling. J Pathol 2013; 230:59-69.; PMID:23335387; http://dx.doi.org/10.1002/path.4168
17. Ki KD, Lee SK, Tong SY, Lee JM, Song DH, Chi SG. Role of 50-CpG island hypermethylation of the FHIT gene in cervical carcinoma. J Gynecol Oncol 2008; 19:117-22.; PMID:19471558; http://dx.doi.org/10.3802/jgo.2008.19.2.117
18. Narayan G, Goparaju C, rias-Pulido H, Kaufmann AM, Schneider A, Durst M, Mansukhani M, Pothuri B, Murty VV. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer 2006; 5: 16.; PMID:16700909; http://dx.doi.org/10.1186/1476-4598-5-16
19. De Strooper LM, Meijer CJ, Berkhof J, Hesselink AT, Snijders PJ, Steenbergen RD, Heideman D. A. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions. Cancer Prev Res (Phila) 2014; 7:1251-7.; PMID:25281488; http://dx.doi.org/10.1158/1940-6207.CAPR-14-0237
20. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, Gunderson KL. Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics 2009; 1:177-200.; PMID:22122642; http://dx.doi.org/10.2217/epi.09.14
21. Choi CH, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, Lee SJ, Lee JH, Bae DS, Kim BG. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett 2007; 255:26-33.; PMID:17467893; http://dx.doi.org/10.1016/j.canlet.2007.03.015
22. Peng L, Yang Z, Tan C, Ren G, Chen J. Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma. Mol Med Rep 2013; 7:1055-61.; PMID:23358566
23. Huang Q, Liu Z, Xie FM, Liu C, Shao F, Zhu CL, Hu S. Fragile histidine triad (FHIT) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathway. Scientific World J 2014; 2014: 179698
24. Ingvarsson S. FHIT alterations in breast cancer. Semin Cancer Biol 2001; 11:361-6.; PMID:11562178; http://dx.doi.org/10.1006/scbi.2001.0391
25. Lung HL, Lo PH, Xie D, Apte SS, Cheung AK, Cheng Y, Law EW, Chua D, Zeng YX, Tsao SW. et al. Characterization of a novel epigenetically-silenced, growthsuppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 2008; 123:401-8.; PMID:18449890; http://dx.doi.org/10.1002/ijc.23528
26. Lindquist D, Kvarnbrink S, Henriksson R, Hedman H. LRIG and cancer prognosis. Acta Oncol 2014; 53:1135-42.; PMID:25180912; http://dx.doi.org/10.3109/0284186X.2014.953258
27. Lindstrom AK, Ekman K, Stendahl U, Tot T, Henriksson R, Hedman H, Hellberg D. LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking. Int J Gynecol Cancer 2008; 18:312-7.; PMID:17624990; http://dx.doi.org/10.1111/j.1525-1438.2007.01021.x
28. Thompson PA, Ljuslinder I, Tsavachidis S, Brewster A, Sahin A, Hedman H, Henriksson R, Bondy ML, Melin BS. Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer. Cancer Res 2014; 74:2928-35.; PMID:24879564; http://dx.doi.org/10.1158/0008-5472.CAN-13-2112
29. Turker MS. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 2002; 21:5388-93.; PMID:12154401; http://dx.doi.org/10.1038/sj.onc.1205599
30. Ku GM, Pappalardo F, Luo CC, German MS, McManus MT. An siRNA screen in pancreatic b cells reveals a role for Gpr27 in insulin production. PLoS Genet 2012; 8:e1002449.; PMID:22253604; http://dx.doi.org/10.1371/journal.pgen.1002449
31. Cui J, Yin Y, Ma Q, Wang G, Olman V, Zhang Y, Chou WC, Hong CS, Zhang C, Cao S. et al. Comprehensive characterization of the genomic alterations in human gastric cancer. Int J Cancer 2015; 137:86-95.; PMID:25422082; http://dx.doi.org/10.1002/ijc.29352
32. Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P. et al. DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics 2010; 11:701.; PMID:21156036; http://dx.doi.org/10.1186/1471-2164-11-701
33. De Angelis PM, Clausen OP, Schjolberg A, Stokke T. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 1999; 80:526-35.; PMID:10408863; http://dx.doi.org/10.1038/sj.bjc.6690388
34. Touleimat N, Tost J. Complete pipeline for Infinium ((R)) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 2012; 4:325-41.; PMID:22690668; http://dx.doi.org/10.2217/epi.12.21
35. Lyng H, Lando M, Brovig RS, Svendsrud DH, Johansen M, Galteland E, Brustugun OT, Meza-Zepeda LA, Myklebost O, Kristensen GB. et al. GeneCount: Genome-wide calculation of absolute tumor DNA copy numbers from array CGH data. Genome Biol 2008; 9:R86.; PMID:18500990; http://dx.doi.org/10.1186/gb-2008-9-5-r86
36. Farkas SA, Milutin-Gasperov N, Grce M, Nilsson TK. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer. Epigenetics 2013; 8:1213-25.; PMID:24030264; http://dx.doi.org/10.4161/epi.26346
37. Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH, Smith EM. et al. Fundamental differences in cell cycle deregulation in human papillomaviruspositive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 2007; 67:4605-19.; PMID:17510386; http://dx.doi.org/10.1158/0008-5472.CAN-06-3619
38. Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, Fearon ER, Cho KR. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 2007; 67:10163-72.; PMID:17974957; http://dx.doi.org/10.1158/0008-5472.CAN-07-2056
39. Scotto L, Narayan G, Nandula SV, rias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M. et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes Cancer 2008; 47:755-65.; PMID:18506748; http://dx.doi.org/10.1002/gcc.20577
40. Steenbergen RD, Parker JN, Isern S, Snijders PJ, Walboomers JM, Meijer CJ, Broker TR, Chow LT. Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes. J.Virol 1998; 72:749-57.; PMID:9420282
41. Snijders PJ, van Duin M, Walboomers JM, Steenbergen RD, Risse EK, Helmerhorst TJ, Verheijen RH, Meijer CJ. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and highrisk human papillomavirus DNA. Cancer Res 1998; 58:3812-8.; PMID:9731489
42. Bijl J, van Oostveen JW, Kreike M, Rieger E, van der Raaij-Helmer LM, Walboomers JM, Corte G, Boncinelli E, van den Brule AJ, Meijer CJ. Expression of HOXC4, HOXC5, and HOXC6 in human lymphoid cell lines, leukemias, and benign and malignant lymphoid tissue. Blood 1996; 87:1737-45.; PMID:8634419
43. Benjamini Y, Hochberg Y. Controlling the false discoveryrate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57:289-300